| Identification | Back Directory | [Name]
TXNIP-IN-1 | [CAS]
1268955-50-5 | [Synonyms]
TXNIP-IN-1
2-{1,3-dioxo-1H,2H,3H-pyrrolo[3,4-c]pyridin-2-yl}-3 -methylbutanoic acid
2H-Pyrrolo[3,4-c]pyridine-2-acetic acid, 1,3-dihydro-α-(1-methylethyl)-1,3-dioxo-
thioredoxin-interacting,inhibit,diabetes,Inhibitor,TRX,TXNIP IN 1,protein,TXNIP,thioredoxin,TXNIPIN1 | [Molecular Formula]
C12H12N2O4 | [MDL Number]
MFCD18487520 | [MOL File]
1268955-50-5.mol | [Molecular Weight]
248.23 |
| Chemical Properties | Back Directory | [Boiling point ]
443.5±25.0 °C(Predicted) | [density ]
1.410±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
3.25±0.10(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
TXNIP-IN-1 is TXNIP-TRX (thioredoxin-interacting protein- thioredoxin) complex inhibitor extracted from patent US20200085800A1, Compound 1. TXNIP-IN-1 can be used in the research of TXNIP-TRX complex associated metabolic disorder (diabetes), cardiovascular disease, or inflammatory disease[1]. | [References]
[1] Rama Natarajan, et al. Txnip-trx complex inhibitors and methods of using the same. US20200085800A1. |
|
|